Ryuji Hamamoto
Ryuji Hamamoto (Ph.D.)
Title
Team Director

Members

  • Team director
    Ryuji Hamamoto
  • Deputy team director
    Masaaki Komatsu
  • Senior research scientist
    Ken Asada
  • Senior research scientist
    Satoshi Takahashi
  • Postdoctoral researcher
    Amina Bolatkan
  • Postdoctoral researcher
    Hiromi Matsumoto
  • Technical scientist
    Norio Shinkai
  • Technical staff I
    Hiroko Kondo
  • Technical staff I
    Shigemi Yamada
  • Visiting scientist
    Kazuma Kobayashi
  • Visiting scientist
    Syuzo Kaneko
  • Visiting scientist
    Masayoshi Yamada
  • Part-time worker I
    Yusuke Sakaguchi
  • Part-time worker I
    Tomonori Taniguchi

Introduction

Laboratory's photo

Our team is collaborating with medical institutions, primarily the National Cancer Center, to analyze large-scalemedical data using the latest AI technology. Our goal is to elucidate disease mechanisms and apply our findings to the development of new diagnostic methods and drug discovery. We are promoting research with a particular focuson the clinical application (social implementation) of our findings, and to date, we have obtained pharmaceutical approval and certification under the Pharmaceutical and Medical Devices Act for multiple research findings, which have been applied in clinical practice.

Main Research Field
Molecular Biology & Genetics
Research Field
Biology & Biochemistry / Immunology / Clinical Medicine / Computer Science
Research Subjects
Analysis of histone modification status in cancer tissues by machine learning and deep learning
Analysis of medical imaging data by machine learning and deep learning
Multi-omics analysis of cancer by machine learning and deep learning
RIKEN Website URL

Introduction Video

Talks by Cancer Translational Research Team thumbnails
Poster(s)

Research Achievements

Related posts

posted on September 18, 2018 14:00Pressrelease